Checkpoint Therapeutics, Inc. Financial Ratios — CKPT Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-51.85	-79.03	-157.05	-95.3	-66.36	-115.27	-181.47	-555.46	-875.4
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-2,240.85	-862.41	-1,320.29	-1,047.92	-1,454.92	-2,170.35	-21,165.3	-30,381.77	-50,629.13	-137,009.76
Operating Margin (%)	-2,240.85	-862.41	-1,320.29	-1,047.92	-1,454.92	-2,170.35	-21,165.3	-30,381.77	-50,629.13	-137,009.76
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-2,354.58	-873.97	-1,314.61	-1,037.28	-1,446.96	-2,159.12	-21,145.52	-32,616.67	-50,336.89	-137,170.73
Profit Margin (%)	-2,354.58	-873.97	-1,314.61	-1,037.28	-1,446.96	-2,159.12	-21,145.52	-32,616.67	-50,336.89	-137,170.73
Net Income to Common Margin (%)	-2,354.58	-873.97	-1,314.61	-1,037.28	-1,446.96	-2,159.12	-21,145.52	-32,616.67	-50,336.89	-137,170.73
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Total Debt	2	- -	- -	- -	- -	- -	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	2	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-0.19	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBITDA	3.63	1.58	0.84	0.6	1.05	1.76	0.96	0.21	0.09	0.12
Total Debt/EBIT	-0.19	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBIT	3.63	1.58	0.84	0.6	1.05	1.76	0.96	0.21	0.09	0.12
EBITDA to Interest Expense	-56.26	-64.43	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-67	-73.62	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-56.26	-64.43	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-27.42	-101.03	-275.66	-383.12	-445.39	-336.15	-358.64	-1,975.06	-5,844.74	-4,960.09
Long-Term Debt/Equity (%)	5.32	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-21.61	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	4.87	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	5.32	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Capital (%)	-21.61	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	4.87	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt to Equity	-103.35	-108.61	-127.82	-186.3	-138.36	-115.24	-184.01	61.94	37.77	52.31
Net Debt/Capital (%)	77.54	49.12	24.57	18.74	17.84	22.16	21.5	4.4	1.54	1.75
EBITDA	-13	-22	-23	-37	-25	-23	-57	-58	-52	-56
EBITDA-CapEx	-16	-25	-23	-37	-25	-23	-57	-58	-52	-56
Operating Income (Loss)	-13	-22	-23	-37	-25	-23	-57	-58	-52	-56

Liquidity (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Cash Ratio	28.17	9.55	3.02	1.68	3.21	5.65	2.11	0.37	0.27	0.33
Current Ratio	28.3	9.8	3.36	1.9	3.32	5.9	2.14	0.41	0.29	0.37
Quick Ratio	28.2	9.78	3.07	1.8	3.22	5.65	2.11	0.37	0.27	0.33
CFO/Avg Current Liab	- -	-3.64	-3.08	-2.65	-2.02	-2.16	-1.58	-1.96	-1.86	-1.61
Common Equity/Total Assets	-27.42	-101.03	-275.66	-383.12	-445.39	-336.15	-358.64	-1,975.06	-5,844.74	-4,960.09
Long-Term Debt/Equity (%)	5.32	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-21.61	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	4.87	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	5.32	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Capital (%)	-21.61	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	4.87	- -	- -	- -	- -	- -	- -	- -	- -	- -
CFO/Total Liabilities	-26.02	-270.9	-242.64	-197.09	-263.25	-229.33	-101.25	-175.61	-258.29	-154.76
CFO/CapEx	-0.44	-3.15	-38.65	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-0.08	25.86	1.82	-7.14	-3.89	6.82	-2.27	-43.05	-115.32	-92.49

Working Capital (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Market Capitalization	- -	172	88	52	61	148	236	45	43	127
- Cash & Cash Equivalents	50	35	19	22	26	41	55	12	5	7
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-48	137	69	30	35	107	182	33	38	120
Total Capital	-11	-36	-59	-95	-120	-143	-200	-262	-314	-371
Total Debt/Capital (%)	-21.61	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt / EV	-0.05	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	53.41	39.73	8.55	20.28	100.26	678.07	172.3	368.86	2,935.47
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	172	88	52	61	148	236	45	43	127
Diluted Enterprise Value	-48	137	69	30	35	107	182	33	38	120
EV per Share	- -	63.71	30.3	10.5	9.81	19.2	23.9	3.74	2.03	3.03
TTM Sales	1	3	2	4	2	1	- -	- -	- -	- -
TTM EBITDA	-13	-22	-23	-37	-25	-23	-57	-58	-52	-56
TTM Operating Income	-13	-22	-23	-37	-25	-23	-57	-58	-52	-56
TTM Cash Flow to Firm	-1	-10	-15	-26	-21	-17	-26	-58	-48	-31
TTM Free Cash Flow to Firm	2	-6	-15	-26	-21	-17	-26	-58	-48	-31

Multiples (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Price/Free Cash Flow	- -	-25.38	-5.83	-2.01	-2.84	-8.94	-8.99	-0.78	-0.9	-4.08
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-48	137	69	30	35	107	182	33	38	120
Low Price	- -	50	33.5	15	11.2	10.5	22.2	3.56	1.3	1.38
EV/Sales	- -	53.41	39.73	8.55	20.28	100.26	678.07	172.3	368.86	2,935.47
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	-7.35	-9.15	-2.68	-4.11	-5.16	-4.15	-1.89	-1.1	-1.68
Price/Earnings High	- -	-14.39	-14.96	-4.94	-7.43	-10.89	-7.21	-4.62	-2.95	-3.17
Price/Earnings Low	- -	-4.8	-3.34	-1.18	-1.6	-2.54	-2.98	-0.5	-0.47	-0.97
Price/Book Value	- -	-4.74	-1.49	-0.54	-0.51	-1.03	-1.18	-0.17	-0.14	-0.34
Price/Book Value Average	- -	-4.54	-3.52	-1.02	-0.85	-0.83	-1.18	-0.45	-0.18	-0.25
Price/Book Value High	- -	-8.89	-5.75	-1.88	-1.53	-1.75	-2.05	-1.1	-0.49	-0.48
Price/Book Value Low	- -	-2.96	-1.28	-0.45	-0.33	-0.41	-0.84	-0.12	-0.08	-0.15
Price/Tangible Book Value	- -	5.34	5.83	4.4	3.22	4.18	7.95	-2.32	-3.29	-10.06
Price/Tangible Book Value Average	- -	5.11	13.8	8.25	5.39	3.37	7.91	-6.07	-4.37	-7.46
Price/Tangible Book Value High	- -	10	22.56	15.21	9.74	7.1	13.74	-14.83	-11.71	-14.14
Price/Tangible Book Value Low	- -	3.33	5.04	3.63	2.1	1.66	5.67	-1.61	-1.87	-4.34
Price/Sales	- -	67.06	50.88	14.82	35.55	138.4	882.31	235.15	416.7	3,096.54
Price/Sales Average	- -	64.27	120.29	27.77	59.45	111.5	878.25	616.03	553.82	2,298.14
Price/Sales High	- -	125.74	196.69	51.23	107.48	235.02	1,525.17	1,505.26	1,483.02	4,354.51
Price/Sales Low	- -	41.91	43.93	12.22	23.15	54.84	629.81	163.83	236.56	1,335.38
Price/Cash Flow	- -	-17.32	-5.68	-2.01	-2.84	-8.94	-8.99	-0.78	-0.9	-4.08
Price/Cash Flow Average	- -	-16.6	-13.42	-3.77	-4.75	-7.2	-8.95	-2.06	-1.2	-3.03
Price/Cash Flow High	- -	-32.48	-21.94	-6.96	-8.59	-15.18	-15.54	-5.02	-3.21	-5.74
Price/Cash Flow Low	- -	-10.83	-4.9	-1.66	-1.85	-3.54	-6.42	-0.55	-0.51	-1.76
Price/Free Cash Flow Average	- -	-24.33	-13.78	-3.77	-4.75	-7.2	-8.95	-2.06	-1.2	-3.03
Price/Free Cash Flow High	- -	-47.59	-22.53	-6.96	-8.59	-15.18	-15.54	-5.02	-3.21	-5.74
Price/Free Cash Flow Low	- -	-15.86	-5.03	-1.66	-1.85	-3.54	-6.42	-0.55	-0.51	-1.76
EV/Sales Average	- -	50.62	109.14	21.5	44.18	73.36	674.01	553.18	505.97	2,137.06
EV/Sales High	- -	112.09	185.54	44.95	92.22	196.88	1,320.94	1,442.41	1,435.18	4,193.44
EV/Sales Low	- -	28.26	32.78	5.94	7.88	16.7	425.58	100.97	188.71	1,174.31
EV/EBITDA Average	3.63	-5.87	-8.27	-2.05	-3.04	-3.38	-3.18	-1.82	-1	-1.56
EV/EBITDA High	3.63	-13	-14.05	-4.29	-6.34	-9.07	-6.24	-4.75	-2.83	-3.06
EV/EBITDA Low	3.63	-3.28	-2.48	-0.57	-0.54	-0.77	-2.01	-0.33	-0.37	-0.86
EV/EBIT Average	3.63	-5.87	-8.27	-2.05	-3.04	-3.38	-3.18	-1.82	-1	-1.56
EV/EBIT High	3.63	-13	-14.05	-4.29	-6.34	-9.07	-6.24	-4.75	-2.83	-3.06
EV/EBIT Low	3.63	-3.28	-2.48	-0.57	-0.54	-0.77	-2.01	-0.33	-0.37	-0.86
Last Price	- -	80	38.8	18.2	17.2	26.5	31.1	5.11	2.29	3.2
High Price	- -	150	150	62.9	52	45	53.76	32.71	8.15	4.5
Enterprise Value Average	-48	130	188	75	75	78	181	106	52	88
Enterprise Value High	-48	288	320	158	158	210	354	277	148	172
Enterprise Value Low	-48	73	57	21	13	18	114	19	19	48

Shares Outstanding	2	2	3	3	5	7	8	10	28	54
Diluted Weighted Avg Shares	2	2	2	3	4	6	8	9	19	40
Basic Weighted Avg Shares	2	2	2	3	4	6	8	9	19	40
Revenue per Share	0.24	1.19	0.76	1.23	0.48	0.19	0.04	0.02	0.01	- -
EBITDA per Share	-5.41	-10.29	-10.07	-12.87	-7.04	-4.16	-7.46	-6.6	-2.78	-1.42
Operating Income per Share	-5.41	-10.29	-10.07	-12.87	-7.04	-4.16	-7.46	-6.6	-2.78	-1.42
Basic EPS, GAAP	-5.69	-10.43	-10.03	-12.74	-7	-4.13	-7.45	-7.09	-2.77	-1.42
Basic EPS from Cont Ops	-5.69	-10.43	-10.03	-12.74	-7	-4.13	-7.45	-7.09	-2.77	-1.42
Diluted EPS, GAAP	-5.69	-10.43	-10.03	-12.74	-7	-4.13	-7.45	-7.09	-2.77	-1.42
Diluted EPS from Cont Ops	-5.69	-10.43	-10.03	-12.74	-7	-4.13	-7.45	-7.09	-2.77	-1.42
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.45	-4.62	-6.84	-9.04	-6.05	-2.96	-3.46	-6.51	-2.54	-0.78
Free Cash Flow per Basic Share	-1.49	-6.09	-7.01	-9.04	-6.05	-2.96	-3.46	-6.51	-2.54	-0.78
Cash & Equivalents per Share	20.64	16.29	8.5	7.7	7.39	7.3	7.2	1.37	0.26	0.17
Book Value per Share	-5.69	-16.87	-26.1	-33.41	-34.02	-25.65	-26.29	-29.71	-16.77	-9.34
Tangible Book Value per Share	18.99	14.99	6.65	4.13	5.34	6.34	3.91	-2.21	-0.7	-0.32

Checkpoint Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)